This role is considered Virtual.
Overview
We are looking for an experienced and talented Business Account Executive (BAE) to commercially represent GIVLAARI® and OXLUMO® in the United States and have a significant impact on the lives of AHP patients. AHP's represent a sub-group of Porphyrias, characterized by the occurrence of neuro-visceral attacks with or without cutaneous manifestations. AHP's include four disorders: acute intermittent porphyria (the most common), variegate porphyria, hereditary coproporphyria, and a genetic deficit of delta-aminolaevulinic acid dehydratase. PH1 is a rare, life-threatening disease that can cause serious damage to kidneys and progressively to other organs. PH1 is a little-known condition and patients often spend years undiagnosed and misdiagnosed.
The BAE will be principally responsible for driving physician and patient identification, disease awareness, overall market development, and brand awareness within their ascribed territory. The BAE will be responsible for achieving territory targets and other business objectives through account and customer strategies, while also partnering & collaborating very closely with internal and external stakeholders to effectively manage all aspects of the regional business. The achievement of targets will be based in Alnylam's values: our commitment to people, sense of urgency, passion for excellence, innovation & discovery, and open culture as well as our unwavering commitment to integrity.
The BAE will report to the Regional Business Director (RBD) for their respective region.
Key Responsibilities
- Drive patient identification through appropriate HCP driven strategies including market development, increase brand awareness through building and executing a territory strategy/account plan; continuously assess opportunities within markets and accounts to launch successfully.
- Effectively prioritize and manage time, activities, and resources in order to optimize access to academic and community HCPs.
- Build and maintain relationships with HCPs and office staff by maximizing their time through planning, leveraging insights, and conducting post-call analysis refining tactics based on opportunities.
- Proactively build effective working relationships with internal/external stakeholders; drive agreement/decisions from multiple stakeholders; demonstrated high level of emotional intelligence adapting communication based on different stakeholders.
- Collaborate with stakeholders across all commercial departments including; patient services, field reimbursement, and others to ensure access at site of care and that logistics are in place to administer medications.
- Collaborate with key accounts and physicians to build individual account plans to drive patient identification through market development and physician education; achieve sales goals, and maintain relationships in order to maximize sales results.
- Execute speaker programs, local sponsorships, displays and exhibits, both in and out of office across multiple account types: academic institutions, physician offices, infusion centers, and alternate site locations.
- Routinely report territory-level market dynamics and trends, including prescriber opinion and competitive activity to RBD as required.
- Bachelor's degree required
- 5+ years of demonstrated success in biotech, specialty pharmaceuticals, or medical devices.
- Experience, success and relationships in Gastroenterology, Hepatology, Neurology, Hematology/Oncology, pediatirc and adult Nephrology and/or Urology are preferred but not required.
- Buy & Bill understanding and experience working with HUB patient services preferred but not required.
- Thorough understanding of site of care identification, development and education.
- Strong examples of applied entrepreneurial mindset, business analytics and data analysis required.
- Experience supporting biologic therapy administered by designated HCPs preferred.
- Experience driving, leading and delivering upon territory-level cross functional business planning.
- Must be familiar with relevant legal and regulatory environment in biotech/pharmaceutical industry.
- Strong communication and listening skills.
- Effective at managing complex individualized cases in a compliant manner.
- Overnight travel required including travel to Boston, congresses and large geographical territories
- Candidates must have a valid driver's license.
- Must live in the assigned territory.
About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.